Bolt Biotherapeutics announces 1-for-20 reverse stock split effective June 6, 2025

Bolt Biotherapeutics, Inc.

Reverse stock split ratio 1:20 approved by board on May 27, 2025.
Effective at 5:00pm ET on June 6, 2025; trading starts split-adjusted June 9.
Ticker remains BOLT on Nasdaq Capital Market; new CUSIP 097702203.
No fractional shares issued; cash paid in lieu of fractional shares.
Par value unchanged at $0.00001; all shares and equity awards adjusted proportionally.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.